Related Experiment Video
Updated: Sep 8, 2025

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
Published on: November 22, 2019
Directed Acyclic Graphs in Oncology Research: Applications and Illustrated Example
Analisa Jia1,2, Lisa Kuramoto3, Brian Lam1
1Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
None:
Directed acyclic graphs (DAG) are increasingly recognized as powerful tools in research and can be used for elucidating complex causal relationships inherent in cancer development, progression, and treatment outcomes. In oncology, in which multifactorial risk factors are the norm, the ability to visualize and interrogate these relationships is critical. In observational studies, DAGs offer a rigorous framework for identifying confounders, mediators, and colliders, allowing researchers to estimate causal effects. This study presents the development and application of a DAG in a real-world observational study involving skin cancer. We outline practical steps for constructing DAGs and discuss how to use them to select variables that help control for confounding. Our approach provides a valuable guide for oncologists, epidemiologists, and other cancer researchers aiming to enhance the transparency and validity of causal claims across a wide range of oncologic contexts-from prevention and early detection to survivorship and health disparities.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

